Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients with Locally Advanced Carcinoma of the Bladder

PURPOSE: This two-arm phase II multicenter trial was designed to assess the efficacy and toxicity of neoadjuvant paclitaxel, gemcitabine, and carboplatin (PCaG) in patients with invasive bladder cancer. METHODS: Patients in arm I had either clinical stage T2 with hydronephrosis or T3 bladder cancer....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Smith, David C., Mackler, Niklas J, Dunn, Rodney L., Hussain, Maha, Wood, David, Lee, Cheryl T., Sanda, Martin, Vaishampayan, Ulka, Petrylak, Daniel P., Quinn, David I., Beekman, Kathleen, Montie, James E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716704/
https://ncbi.nlm.nih.gov/pubmed/18930256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2008.08.075
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi